Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First in Human Phase 1 Study in Healthy Volunteers and in Participants With Frontotemporal Dementia (FTD) With Granulin Mutation

NCT03636204 is registered in ClinicalTrials.gov with Alector Inc. as lead sponsor.

NCT NCT03636204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03636204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First in Human Phase 1 Study in Healthy Volunteers and in Participants With Frontotemporal Dementia (FTD) With Granulin Mutation
Lead sponsor
Alector Inc.
Phase
Phase 1
Overall status
Completed
Start date
September 14, 2018
Completion date
December 31, 2019
Enrollment
64 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

frontotemporal dementia, healthy